• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Progenics Pharmaceuticals Inc

+ Add to Watchlist


3.689 EUR 0.234 5.96%

As of 15:23:09 ET on 10/31/2014.

Snapshot for Progenics Pharmaceuticals Inc (PGP)

Open: 3.841 Day's Range: 3.689 - 3.945 Volume: 2,000
Previous Close: 3.923 52wk Range: 2.253 - 5.334 1-Yr Rtn: +42.32%

Stock Chart for PGP

No chart data available.
  • PGP:GR 3.945
  • 1D
  • 1M
  • 1Y
Interactive PGP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PGP

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.1600
Est. PEG Ratio -
Market Cap (M EUR) 256.59
Shares Outstanding (M) 69.56
30 Day Average Volume 201
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PGP

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PGP

Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.

Mark Robert BakerChief Executive OfficerRobert J IsraelExec VP:Medical Affairs
Hagop YoussoufianExec VP:Research & DevelopmentNitya G RaySenior VP:Manufacturing
More Company Profile & Key Executives for PGP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil